These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlation between Liu X; Wang SC; Ni M; Xie Q; Zhang YF; Lv WF; Geng GY Abdom Radiol (NY); 2022 Apr; 47(4):1255-1264. PubMed ID: 35138462 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
7. The value of Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193 [TBL] [Abstract][Full Text] [Related]
9. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069 [TBL] [Abstract][Full Text] [Related]
10. Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters. Koh YW; Lee SJ; Park SY Lung Cancer; 2017 Feb; 104():31-37. PubMed ID: 28212997 [TBL] [Abstract][Full Text] [Related]
11. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer. Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of Grut H; Dueland S; Line PD; Revheim ME Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):218-225. PubMed ID: 29026950 [TBL] [Abstract][Full Text] [Related]
13. Volumetric parameters on Liu G; Hu Y; Cheng X; Wang Y; Gu Y; Liu T; Shi H BMC Cancer; 2019 Aug; 19(1):790. PubMed ID: 31395059 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma. Hwang SH; Lee JW; Cho HJ; Kim KS; Choi GH; Yun M Clin Nucl Med; 2017 Jan; 42(1):34-39. PubMed ID: 27775949 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of FDG-PET/CT Total Lesion Glycolysis for Patients with Resectable Distal Bile Duct Adenocarcinoma. Lee EJ; Chang SH; Lee TY; Yoon SY; Cheon YK; Shim CS; So Y; Chung HW Anticancer Res; 2015 Dec; 35(12):6985-91. PubMed ID: 26637926 [TBL] [Abstract][Full Text] [Related]
17. Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma. Fonti R; Larobina M; Del Vecchio S; De Luca S; Fabbricini R; Catalano L; Pane F; Salvatore M; Pace L J Nucl Med; 2012 Dec; 53(12):1829-35. PubMed ID: 23071351 [TBL] [Abstract][Full Text] [Related]
18. Prognostic role of baseline Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563 [TBL] [Abstract][Full Text] [Related]
19. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial. Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer. Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]